Webinar | APOL1-mediated kidney disease: Overview and Implications for Care | AKF

preview_player
Показать описание
APOL1 as a potential genetic marker for kidney disease remains a topic new to many healthcare professionals.

It is estimated that 45% of people with African ancestry in the US carry at least one high-risk APOL1 genetic variant and 13% carry two variants, which could have certain impacts on the health of a segment of your patient population.
Рекомендации по теме